Julie Jordan - Mar 7, 2023 Form 3 Insider Report for Homology Medicines, Inc. (FIXX)

Role
Chief Medical Officer
Signature
/s/ Paul Alloway, Attorney-in-Fact for Julie Jordan
Stock symbol
FIXX
Transactions as of
Mar 7, 2023
Transactions value $
$0
Form type
3
Date filed
3/16/2023, 05:03 PM
Next filing
Aug 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding FIXX Common Stock 2.52K Mar 7, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding FIXX Employee Stock Option (Right to Buy) Mar 7, 2023 Common Stock 65K $6.53 Direct F1
holding FIXX Employee Stock Option (Right to Buy) Mar 7, 2023 Common Stock 56K $2.71 Direct F2
holding FIXX Employee Stock Option (Right to Buy) Mar 7, 2023 Common Stock 9K $3.59 Direct F3
holding FIXX Employee Stock Option (Right to Buy) Mar 7, 2023 Common Stock 143K $1.60 Direct F4
holding FIXX Restricted Stock Units Mar 7, 2023 Common Stock 350 Direct F5, F6
holding FIXX Restricted Stock Units Mar 7, 2023 Common Stock 5.36K Direct F6, F7
holding FIXX Restricted Stock Units Mar 7, 2023 Common Stock 1.34K Direct F6, F8
holding FIXX Restricted Stock Units Mar 7, 2023 Common Stock 24K Direct F6, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests or has vested as to 25% of the underlying shares on May 3, 2022 and in 36 substantially equal monthly installments upon the Reporting Person's completion of each full month of service thereafter so that such option will become fully vested on May 3, 2025.
F2 The option vests in 48 substantially equal monthly installments upon the Reporting Person's completion of each full month of service following January 1, 2022 so that such option will become fully vested on January 1, 2026.
F3 The option vests in 48 substantially equal monthly installments upon the Reporting Person's completion of each full month of service following January 1, 2022 so that such option will become fully vested on January 1, 2026.
F4 The option vests in 48 substantially equal monthly installments upon the Reporting Person's completion of each full month of service following January 1, 2023 so that such option will become fully vested on January 1, 2027.
F5 The restricted stock units will vest and settle in full on August 2, 2023.
F6 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.
F7 The restricted stock units will vest and settle as to one half of the restricted stock units on each of January 1, 2024 and January 1, 2025.
F8 The restricted stock units will vest and settle as to one half of the restricted stock units on each of January 1, 2024 and January 1, 2025.
F9 The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2023 so that such RSUs will become fully vested on January 1, 2026.

Remarks:

Exhibit 24 - Power of Attorney.